Cancer Center Amsterdam - Cancer Biology and Immunology

Research Output


A phase II study of selinexor(KPT-330) combined with bortezomib and dexamethasone (SVD) for induction and consolidation for patients with progressive or refractory multiple myeloma: The selvedex trial

Broijl, A., Asselbergs, E. L., Minnema, M. C., Lonergan, S., van der Holt, B., van de Donk, N., Zweegman, S. & Sonneveld, P., 2018, (Congr Eur Hematol Assoc (EHA) SO - Congr Eur Hematol Assoc (EHA))

Research output: Book/ReportBookAcademicpeer-review

Proceedings of the Fourteenth International Symposium on Human Chlamydial Infections

Ouburg, S. & Morre, S. A., 1 Jul 2018, Gildeprint. 742 p.

Research output: Book/ReportBookAcademicpeer-review


Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study

Nielsen, L., Stege, C., Witte, B., Holt, B., Mellqvist, U-H., Salomo, M., Levin, M-D., Hansson, M., Plesner, T., Szatkowski, D., Haukas, E., Gimsing, P., Sonneveld, P., Abildgaard, N., Waage, A. & Zweegman, S., 2017, 2 p. (Quality of life research. Conference: 24th annual conference of the international society for quality of life research, ISOQOL 2017. United states; vol. 26)

Research output: Book/ReportBookAcademicpeer-review